Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nuclear Medicine Review. Central & Eastern Europe|May 21, 2011
The value of the Duke Activity Status Index (DASI) in predicting ischaemia in myocardial perfusion scintigraphy - a prospective studyMarc J George, Shivani A Kasbekar, Dolin Bhagawati, et al.
Plos One|February 3, 2023
Digital technology and patient and public involvement (PPI) in routine care and clinical research-A pilot studyYang Chen, Ali A Hosin, Marc J George, et al.
Current Vascular Pharmacology|November 4, 2010
Early postoperative bleeding in polytrauma patients treated with fondaparinux: literature review and institutional experienceEleftherios Tsiridis, Zakareya Gamie, Marc J George, et al.
Clinical Infection in Practice|February 1, 2021
Aortic thrombosis in COVID-19Helena Wickham, Jerry C H Tam, Xin Hui S Chan, et al.
Plos One|October 26, 2016
A Comparison of Human Neutrophils Acquired from Four Experimental Models of InflammationAlexander A Maini, Marc J George, Madhur P Motwani, et al.
JCI Insight|March 23, 2018
Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammationMadhur P Motwani, Romain A Colas, Marc J George, et al.
Journal of the American Heart Association|June 10, 2020
Novel Insights Into the Effects of Interleukin 6 Antagonism in Non-ST-Segment-Elevation Myocardial Infarction Employing the SOMAscan Proteomics PlatformMarc J George, Ola Kleveland, Jorge Garcia-Hernandez, et al.
Clinical Pharmacology and Therapeutics|December 15, 2017
Potent Anti-Inflammatory and Pro-Resolving Effects of Anabasum in a Human Model of Self-Resolving Acute InflammationMadhur P Motwani, Frances Bennett, Paul C Norris, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Proteogenomic integration reveals CXCL10 as a potentially downstream causal mediator for IL-6 signaling on atherosclerosisSavvina Prapiadou, Luka Živković, Barbara Thorand, et al.
Circulation|December 28, 2023
Proteogenomic Data Integration Reveals CXCL10 as a Potentially Downstream Causal Mediator for IL-6 Signaling on AtherosclerosisSavvina Prapiadou, Luka Živković, Barbara Thorand, et al.
Pageof 1